Equities research analysts at William Blair decreased their Q4 2025 earnings estimates for shares of Meta Platforms in a research note issued on Thursday, January 30th. William Blair analyst R.
Research analysts at William Blair increased their FY2026 earnings per share (EPS) estimates for Royal Caribbean Cruises in a report issued on Tuesday, January 28th. William Blair analyst S. Zackfia ...
William Blair Large Cap Growth Fund earns an Average Process Pillar rating. The most substantial contributor to the rating is the stability of the management team. Specifically, the fund has not ...
AbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for Skyrizi and Rinvoq by $4 billion.
ResMed stock tumbled Friday after organic sales growth slowed somewhat in the second fiscal quarter. But one analyst remained upbeat on the "mega trends" driving the CPAP maker.Please watch the video ...
The seemingly overnight success of Chinese AI firm DeepSeek has catapulted its founder, Liang Wenfeng, to billionaire status. Here’s how.
Vertex Pharmaceuticals (VRTX) stock rose on Friday after the Food and Drug Administration (FDA) approved its new painkiller, the first of its kind approved by regulators.
After the Phase II failure of its lead asset from Cerevel, AbbVie is resetting expectations and narrowing the clinical ...